Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura

N Engl J Med. 2024 Jul 25;391(4):382-383. doi: 10.1056/NEJMc2406975.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • ADAMTS13 Protein* / deficiency
  • ADAMTS13 Protein* / therapeutic use
  • Bortezomib / therapeutic use
  • Hematologic Agents* / therapeutic use
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Purpura, Thrombotic Thrombocytopenic* / drug therapy
  • Purpura, Thrombotic Thrombocytopenic* / therapy
  • Recombinant Proteins / therapeutic use

Substances

  • ADAMTS13 Protein
  • ADAMTS13 protein, human
  • caplacizumab
  • Recombinant Proteins
  • Hematologic Agents
  • Immunoglobulins, Intravenous
  • Bortezomib